Dormant
ACHR · Archer Aviation Inc.
Last analysed ·
Against its published line
1 name has closed through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 11 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Current thesis
Archer Aviation’s acquisition-led recovery thesis failed when the 2026-09-11 weekly close of $5.58 breached its published $5.65 threshold. Completion of the Boeing transaction remains the business test, but cannot reverse that price invalidation.
Kill line
A weekly close below $5.65 ends the published shelf-recovery thesis; the condition was met by the 2026-09-11 close of $5.58. An announced acquisition delay beyond 2026 would separately invalidate management’s year-end closing timetable.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for ACHR —
As of 13 September 2026, the latest FrontierPicks analysis for Archer Aviation Inc. (ACHR): Archer Aviation’s acquisition-led recovery thesis failed when the 2026-09-11 weekly close of $5.58 breached its published $5.65 threshold. Completion of the Boeing transaction remains the business test, but cannot reverse that price invalidation.
Kill line: A weekly close below $5.65 ends the published shelf-recovery thesis; the condition was met by the 2026-09-11 close of $5.58. An announced acquisition delay beyond 2026 would separately invalidate management’s year-end closing timetable.
Current Thesis
Archer Aviation’s acquisition-led recovery thesis has failed its published price test: the 2026-09-11 weekly close of $5.58 breached the $5.65 threshold, while completion of the Boeing transaction remains the unresolved business test. The September 5 assessment treated that shelf as the remaining support after the August announcement faded. The latest close settles that particular question; a lower replacement threshold would change the original test.
As a price-structure inference, the narrative is dead — the 2026-09-11 close broke the remaining shelf identified in the September 5 research. This describes the published recovery thesis, not the viability of Archer’s aircraft or the eventual acquisition. The underlying proposition remains a transition into autonomous aviation and defense through Wisk, SkyGrid and Insitu, announced on 2026-08-10; completion and subsequent reported results would establish whether that transition reaches the financial statements. Archer acquisition announcement.
Bullish and bearish views on Archer Aviation Inc.
The model's bull view on Archer Aviation Inc. (ACHR), in brief: Flight activity provides operating evidence. The bear view: Published support has already failed. The adjusted market close was $5.58 on 2026-09-11, below the $5.65 September 4 session low used as the September 5 thesis-break threshold. This is an observed invalidation, rather than a forecast of further declines. Losses remain… Both cases follow in full.
Bull Case
- Flight activity provides operating evidence. Archer’s 2026-09-03 release reported more than 70 test flights during August and a completed Salinas–Monterey roundtrip. Those are demonstrated flights; they do not establish commercial passenger revenue. Archer flight-tour announcement.
- Acquisition adds an established business. The 2026-08-10 announcement described Insitu as profitable and generating over $200 million in annual revenue. That supports the proposed business mix, but the acquired revenue remains contingent on closing. Archer acquisition announcement.
Bear Case
- Published support has already failed. The adjusted market close was $5.58 on 2026-09-11, below the $5.65 September 4 session low used as the September 5 thesis-break threshold. This is an observed invalidation, rather than a forecast of further declines.
- Losses remain substantial against revenue. Archer’s 2026-08-10 results reported second-quarter revenue of $5.000 million and an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) loss of $177.1 million. Management guided the third-quarter adjusted EBITDA loss to $170 million–$200 million; a reported loss above $200 million would breach that guidance. Archer second-quarter results.
- Boeing funding has additional conditions. The 2026-08-10 Form 8-K ties Boeing’s potential investment of up to $55 million to an Archer equity offering expected to raise at least $400 million, with approval and other conditions. The commitment is not evidence that financing has been completed. Archer transaction filing.
Setup & Price Structure
The 2026-09-11 adjusted price series records a $5.58 close, a three-month gain of 9.8%, and a price 59.1% below the $13.64 trailing annual high. The 14-period relative strength index was 29.3 on the same date. The positive three-month change does not reverse the observed breach of $5.65, and the momentum reading alone cannot establish a reversal. A moving-average value and slope are unavailable, so distance above a rising average cannot be assessed.
Attention and potential supply are observable, but current crowding is not established. Benzinga’s 2026-08-11 investor-radar article included Archer, and the 2026-09-06 headline paired Archer with Joby as falling air-taxi shares. That coverage sample is too small to establish expanding participation or saturation. The 2026-08-18 Form 424B7 registered 8,261,273 Class A shares for resale by existing holders;
The acquisition consideration also differs from immediately tradable supply. Archer’s 2026-08-10 Form 8-K specifies consideration equal to 19.75% of pre-closing Class A shares, subject to adjustments, and a 12-month transfer restriction on Boeing’s consideration shares with exceptions. Archer transaction filing.
Catalyst Calendar (next 30 days)
For 2026-09-14 through 2026-10-13, no company-confirmed catalyst date was established in the reviewed announcements. The previously published approximately 2026-09-30 antitrust estimate lacks a disclosed filing date and is not a scheduled clearance event. The August 10 transaction filing identifies expiration or termination of the Hart-Scott-Rodino antitrust waiting period as a closing condition. Archer transaction filing.
- 2026-12-31 marks management’s closing horizon. Archer’s 2026-08-10 announcement targeted completion by year-end, rather than a closing specifically scheduled for December 31. Completion determines whether the acquired businesses enter Archer’s reported results; an announced delay beyond 2026 would invalidate that timetable. Archer acquisition announcement.
What Would Change Our Mind
The remaining support shelf has already failed: a weekly close below $5.65 was the published break condition, and the 2026-09-11 close was $5.58. The original recovery case is therefore invalidated. Its outcome cannot be reversed retrospectively by a later rebound.
A weekly close above the previously identified $6.26 pre-announcement reference, accompanied by disclosed acquisition clearance or completion, would justify assessing a separate recovery thesis. That is a conditional reassessment criterion, not a prediction that recovery occurs. The September 11 close supplies neither price confirmation nor evidence of transaction completion.
Correlation Notes
The 2026-09-06 headline grouped Archer and Joby, while Benzinga’s 2026-08-12 coverage described Archer falling alongside Boeing after the acquisition announcement. These are dated instances of shared coverage, not a measured return correlation. Paired return observations are unavailable, and the sample is too small to establish a stable relationship.
This remains a single-name assessment: the 2026-09-11 breach of Archer’s published shelf and the closing conditions disclosed on 2026-08-10 determine the read. Neither an air-taxi group recovery nor a broader defense rally is assumed.
Notes
- All-stock deal: the share count changes materially at closing (~19.75% of the pre-close count issued to Boeing), so per-share metrics computed before close are not comparable after.
- Two Boeing warrants, each covering $100.0M of Class A stock at $13.00 and $17.88, become exercisable from the first anniversary of closing - dated supply above the current range.
- A Form 424B7 filed 2026-08-18 registers 8,261,273 Class A shares for resale by existing holders; the company receives no proceeds from those sales.
- Company guides adjusted EBITDA, not GAAP earnings; the Q3 2026 guide is a $170M-$200M loss, so a 'beat' means a smaller loss, not profit.
- Insitu's >$200M annual revenue does not consolidate into reported results until the acquisition closes, targeted end-2026.
- Restricted stock vests on a recurring schedule; officer Rule 144 filings recur and are programmatic, not necessarily directional.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.
DSGR
Distribution Solutions Group, Inc.
Distribution Solutions Group’s $35.00 cash acquisition remains a completion thesis, with the minority vote and closing settling the case. HSR clearance occurred on 2026-08-20; a daily close below $33.50 invalidates the price thesis.